drugset / Trial / NCT02357485

ADSC Injections for Pain Management of Osteoarthritis in the Human Knee Joint

NCT02357485 ↗

NaSingle-groupOpen-labelTreatment

Summary

This safety and feasibility study used autologous adipose-derived stromal cells (ADSC), the stromal vascular fraction (SVF), to treat 8 osteoarthritic (OA) knees in 6 patients of grade I to III (K-L scale) with initial pain of 4 or greater on a 10 point scale, under Institutional Review Board (IRB) approved protocol.

Timeline

Start
2014-03
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject adipose-derived stromal cells Cell therapy 1.2e+07 cells Other

Indications